XML 45 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
CAPITAL STRUCTURE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 01, 2017
Jun. 18, 2018
Dec. 19, 2017
Nov. 21, 2017
May 25, 2017
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 29, 2018
Sep. 30, 2017
Dec. 31, 2017
Feb. 10, 2017
Sep. 27, 2013
Common stock, shares issued           13,495,394   13,495,394     12,825,393    
Common stock, shares outstanding           13,321,704   13,321,704     12,666,704    
Common stock shares authorized           300,000,000   300,000,000     300,000,000    
Preferred stock shares authorized           100,000,000   100,000,000     100,000,000    
Common stock value           $ 13,495   $ 13,495     $ 12,825    
Reverse stock split, description       the Company effected a one-for-ten (1:10) reverse stock split whereby the Company decreased, by a ratio of one-for-ten (1:10) the number of issued and outstanding shares of Common Stock.                  
Related party accrual for repurchase of shares of common stock               23,244        
Revenue           8,508,367 $ 9,546,951 29,330,684   19,775,398      
Gain on sale of Amplerissimo           $ 146,647 $ 146,647        
Prior to merger [Member]                          
Common stock, shares issued           10,000,000   10,000,000          
Prior to merger [Member] | Amplerissimo Ltd [Member]                          
Common stock, shares issued           2,558,553   2,558,553          
Post Merger [Member]                          
Common stock, shares issued                         12,558,553
Common stock, shares outstanding                         12,558,553
Amplerissimo Ltd [Member] | Equity issued in merger [Member] | Dimitrios Goulielmos [Member]                          
Common stock, shares issued                         10,000,000
SkyPharm [Member]                          
Purchase price                 $ 2,528        
Ownership percentage                 100.00%        
Revenue               $ 1,092,865   1,011,323      
Percentage of ownership interest transferred to company by amplerissimo                 22.00%        
Fiscal 2018 [Member] | Amplerissimo Ltd [Member]                          
Revenue               $ 7,639,022          
Employee [Member] | Potentially dilutive securities [Member] | On January 1, 2018 [Member]                          
Stock options granted               25,000          
Exercise period               4 years          
Exercise price               $ 1.00          
Stock options vested           18,750   18,750          
Stock Purchase Agreement [Member] | Decahedron Ltd [Member]                          
Common stock shares reserved                       170,000  
Stock Purchase Agreement [Member] | Officer and Director [Member]                          
Due to related party                     61,422    
Repurchase of common stock   15,000 20,000                    
Payment for repurchase of common stock     $ 94,495                    
Payment for consideration   $ 69,912         $ 46,488     46,488 $ 33,073    
Repayment of remaining balance               $ 63,446   $ 23,244      
Share purchase agreement [Member] | Fiscal 2018 [Member] | Amplerissimo Ltd [Member]                          
Purchase price               $ 5,811          
Ownership percentage           100.00%   100.00%          
Gain on sale of Amplerissimo               $ 146,647          
Consulting agreement Four [Member] | ArKo European Business & Services [Member]                          
Common stock, shares issued         20,000                
Commencing agreement date         May 25, 2017                
Consulting agreement period         20 months                
Common stock value         $ 154,000                
Price per share         $ 7.70                
Consultant charges         $ 56,138     $ 69,034          
Consulting Agreement [Member] | ArKo European Business & Services [Member]                          
Restricted shares of common stock 500                        
Consulting agreement period 4 months